The fact that we found that RPS6 expression can predict tamoxifen sensitivity and that knockdown of RPS6 desensitized breast cancer cells to tamoxifen exposure by two folds suggests a potential role for RPS6 in the estrogen response pathway, in addition to its role as a protein synthesis regulator. The gene discussed is RPS6; the disease is breast carcinoma.